Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

May 31, 2011

Conditions
Healthy
Interventions
DRUG

Dabigatran etexilate plus dronedarone

dabigatran etexilate 150 mg plus dronedarone 400 mg as single dose

DRUG

Dabigatran etexilate

150 mg as single dose

DRUG

Dabigatran etexilate plus dronedarone

dabigatran etexilate 150 mg plus dronedarone 400 mg as single dose (staggered administration)

DRUG

Dabigatran etexilate plus dronedarone

dabigatran etexilate 150 mg single dose plus dronedarone 400 mg bid

DRUG

Dabigatran etexilate plus dronedarone

dabigatran etexilate 150 mg single dose plus dronedarone 400 mg bid (staggered administration)

Trial Locations (1)

Unknown

1160.112.1 Boehringer Ingelheim Investigational Site, Ulm

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY